Jarshaw Christen L, Omoregie Osariemen, Peck Jennifer D, Pierce Stephanie, Jones Emily J, Hosseinzadeh Pardis, Craig LaTasha B
Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, College of Medicine, University of Oklahoma Health Sciences Center (Dr Jarshaw), Oklahoma City, OK.
Department of Obstetrics and Gynecology, Mountain Area Health Education Center (Dr Jarshaw), Asheville, NC.
AJOG Glob Rep. 2024 Feb 9;4(1):100318. doi: 10.1016/j.xagr.2024.100318. eCollection 2024 Feb.
Vaccination during pregnancy reduces the incidence of infections and their associated adverse outcomes in both mothers and infants. The American College of Obstetricians and Gynecologists has recommended influenza and Tdap vaccination during pregnancy since 2004 and 2013, respectively. Several studies have examined disparities in vaccination rates during pregnancy by race/ethnicity. However, none have included American Indians/Alaska Natives as a specific racial/ethnic group on a national level. Current literature suggests that American Indian/Alaska Native infants experience increased morbidity and mortality from both influenza and pertussis infections compared with most other groups in the United States.
This study aimed to evaluate the uptake of influenza and Tdap vaccinations during pregnancy by race/ethnicity, with a specific focus on American Indian/Alaska Native people.
This cross-sectional study used data from the Pregnancy Risk Assessment Monitoring System. Comparisons of vaccine uptake across racial/ethnic groups (American Indian/Alaska Native, Asian, non-Hispanic Black, non-Hispanic White, Hispanic, and "None of the above") were evaluated using weighted logistic regression analyses to estimate prevalence odds ratios with 95% confidence intervals. Models were adjusted for maternal age, parity, maternal education, marital status, payment method at delivery, prenatal care in first trimester, maternal smoking status, Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) participation, and receipt of influenza vaccine reported by a health care provider.
For both vaccines, Asian respondents had the highest uptake (influenza, 70.1%; Tdap, 68.2%), whereas Black respondents reported the lowest uptake (influenza, 44.4%; Tdap, 57.9%). For the influenza vaccine, American Indian/Alaska Native respondents demonstrated a higher uptake compared with White respondents, and the magnitude of difference increased markedly after adjusting for respondent characteristics (adjusted odds ratio, 1.74; 95% confidence interval, 1.58-1.90). In the unadjusted analyses, Black individuals reported influenza vaccination at approximately half the rate of their White counterparts during pregnancy. This effect was attenuated but remained lower after adjustment for respondent characteristics (adjusted odds ratio, 0.73; 95% confidence interval, 0.70-0.76). For the Tdap vaccine, American Indian/Alaska Native respondents reported lower uptake than White respondents; however, this difference disappeared when adjusted for respondent characteristics (adjusted odds ratio, 0.99; 95% confidence interval, 0.83-1.19). Asian and Hispanic respondents displayed a similar uptake compared with their White counterparts for both vaccines.
Our findings indicate that there are racial/ethnic disparities in influenza and Tdap vaccination rates among pregnant individuals in the United States. Demonstration of increased uptake among American Indian/Alaska Native people in the crude analysis may reflect the success of various public health interventions through Tribal and Indian Health Service hospitals. Nonetheless, vaccination status during pregnancy remains seriously below national guideline recommendations. Greater measures must be taken to support preventative care in marginalized populations, with particular emphasis on community-driven solutions rooted in justice.
孕期接种疫苗可降低母亲和婴儿感染的发生率及其相关不良后果。自2004年和2013年起,美国妇产科医师学会分别建议孕期接种流感疫苗和破伤风类毒素、白喉、百日咳联合疫苗(Tdap)。多项研究探讨了孕期接种疫苗率在种族/族裔方面的差异。然而,尚无研究在全国层面将美国印第安人/阿拉斯加原住民作为一个特定的种族/族裔群体纳入研究。当前文献表明,与美国大多数其他群体相比,美国印第安人/阿拉斯加原住民婴儿因流感和百日咳感染导致的发病率和死亡率更高。
本研究旨在评估按种族/族裔划分的孕期流感疫苗和Tdap疫苗接种情况,特别关注美国印第安人/阿拉斯加原住民。
这项横断面研究使用了来自妊娠风险评估监测系统的数据。采用加权逻辑回归分析评估不同种族/族裔群体(美国印第安人/阿拉斯加原住民、亚裔、非西班牙裔黑人、非西班牙裔白人、西班牙裔以及“以上都不是”)的疫苗接种情况,以估计患病率比值比及95%置信区间。模型对产妇年龄、产次、产妇教育程度、婚姻状况、分娩支付方式、孕早期产前检查、产妇吸烟状况、妇女、婴儿和儿童特别补充营养计划(WIC)参与情况以及医疗服务提供者报告的流感疫苗接种情况进行了调整。
对于这两种疫苗,亚裔受访者的接种率最高(流感疫苗为70.1%;Tdap疫苗为68.2%),而黑人受访者的接种率最低(流感疫苗为44.4%;Tdap疫苗为
57.9%)。对于流感疫苗,美国印第安人/阿拉斯加原住民受访者的接种率高于白人受访者,在对受访者特征进行调整后,差异幅度显著增加(调整后的比值比为1.74;95%置信区间为1.58 - 1.90)。在未调整的分析中,黑人在孕期接种流感疫苗的比例约为白人的一半。在对受访者特征进行调整后,这种影响有所减弱,但仍较低(调整后的比值比为0.73;95%置信区间为0.70 - 0.76)。对于Tdap疫苗,美国印第安人/阿拉斯加原住民受访者报告的接种率低于白人受访者;然而,在对受访者特征进行调整后,这种差异消失了(调整后的比值比为0.99;95%置信区间为0.83 - 1.19)。对于这两种疫苗,亚裔和西班牙裔受访者与白人受访者的接种率相似。
我们的研究结果表明,美国孕期流感疫苗和Tdap疫苗接种率在种族/族裔方面存在差异。在粗分析中美国印第安人/阿拉斯加原住民接种率的增加可能反映了通过部落和印第安健康服务医院开展的各种公共卫生干预措施的成功。尽管如此,孕期接种疫苗状况仍严重低于国家指南建议。必须采取更多措施支持边缘化人群的预防性保健,尤其要强调基于公正的社区驱动解决方案。